|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 361.40 CHF | +0.39% |
|
+2.15% | +10.12% |
| Feb. 16 | ROCHE HOLDINGS AG : Jefferies remains a Sell rating | ZD |
| Feb. 16 | Roche's Late-Stage Trial Win Places Gazyva as First Targeted Treatment for Chronic Autoimmune Kidney Disease | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 370.3 | 400.55 | 371.15 |
| Spread/Res. | -2.40% | -9.77% | -2.63% |
| Spread/Supp. | +2.93% | +17.57% | +22.80% |
| Support | 351.1 | 307.4 | 294.3 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- ROG Stock
- Charts Roche Holding AG
Select your edition
All financial news and data tailored to specific country editions
